{"context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "10040666972", "name": "The New York Times"}}], "author_id": "3310124155", "reply_settings": "everyone", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "lang": "en", "possibly_sensitive": false, "conversation_id": "1249104464579047428", "created_at": "2020-04-13T01:24:23.000Z", "source": "Twitter Web App", "id": "1249508699070177280", "entities": {"mentions": [{"start": 0, "end": 8, "username": "nytimes", "id": "807095"}], "urls": [{"start": 78, "end": 101, "url": "https://t.co/GLIpjlaByI", "expanded_url": "https://finance.yahoo.com/news/diffusion-pharmaceuticals-evaluating-tsc-against-120010293.html", "display_url": "finance.yahoo.com/news/diffusion\u2026"}], "annotations": [{"start": 9, "end": 32, "probability": 0.5059, "type": "Organization", "normalized_text": "Diffusion Pharmaceutical"}, {"start": 59, "end": 63, "probability": 0.3226, "type": "Organization", "normalized_text": "Covid"}]}, "referenced_tweets": [{"type": "replied_to", "id": "1249104464579047428"}], "in_reply_to_user_id": "807095", "text": "@nytimes Diffusion Pharmaceutical has a drug treatment for Covid-19 patients.\nhttps://t.co/GLIpjlaByI"}